Current disease status-First occurrence of the myeloma Posts on Medivizor
Navigation Menu

Current disease status-First occurrence of the myeloma Posts on Medivizor

Risk of adverse events in new versus conventional treatment for multiple myeloma

Posted by on Apr 18, 2018 in Multiple Myeloma | 0 comments

In a nutshell This paper studied the risk of adverse events in patients who receive treatment for multiple myeloma. The use of new drugs increased the risk of low blood count, peripheral neuropathy and blood clots. Some background Multiple myeloma is a cancer of the plasma cells (type of white blood cell). Multiple myeloma can be treated with drugs...

Read More

Combining carfilzomib with cyclophosphamide and dexamethasone for newly diagnosed multiple myeloma

Posted by on Aug 7, 2017 in Multiple Myeloma | 0 comments

In a nutshell This study examined the safety of combining carfilzomib (Kyprolis), cyclophosphamide (Cytoxan), and dexamethasone Decadron) for multiple myeloma. Researchers reported early results on the safety and potential effectiveness of this treatment combination. Some background Advances in first-line treatments have improved response and...

Read More

Three treatment combinations are as effective as four in previously untreated multiple myeloma

Posted by on May 28, 2017 in Multiple Myeloma | 0 comments

In a nutshell This study compared different treatment combinations for previously untreated multiple myeloma, including bortezomib (Velcade), dexamethasone (Ozurdex), cyclophosphamide (Cytoxan), and lenalidomide (Revlimid). This study concluded that a combination of all four therapies did not improve response rates beyond combinations of three...

Read More